BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents. 2013

Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.

A series of 11,12-cyclic carbonate azithromycin-4″-O-carbamoyl glycosyl derivatives were designed, synthesized, and evaluated as antibacterial agents to search for target compounds with excellent activity. The results of preliminary antibacterial tests against eight strains in vitro revealed that all of the title compounds exhibited improved activities with broad spectrum compared with the parent compound. The glycosylated side chains may be the pharmacophores responsible for the improved activity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017963 Azithromycin A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. Azadose,Azithromycin Dihydrate,Azithromycin Monohydrate,Azitrocin,Azythromycin,CP-62993,Goxal,Sumamed,Toraseptol,Ultreon,Vinzam,Zentavion,Zithromax,Zitromax,CP 62993,CP62993,Dihydrate, Azithromycin,Monohydrate, Azithromycin

Related Publications

Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, synthesis and biological evaluation of novel flavone Mannich base derivatives as potential antibacterial agents.
May 2019, Molecular diversity,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
April 2018, Bioorganic & medicinal chemistry letters,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, synthesis and biological evaluation of novel indole-piperazine derivatives as antibacterial agents.
June 2023, Bioorganic & medicinal chemistry letters,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents.
August 2000, Carbohydrate research,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
February 2018, Bioorganic & medicinal chemistry letters,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agents.
April 2021, Bioorganic chemistry,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, Synthesis and Biological Evaluation of Lophanic Acid Derivatives as Antifungal and Antibacterial Agents.
October 2022, Molecules (Basel, Switzerland),
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents.
October 2022, European journal of medicinal chemistry,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents.
July 2021, ACS omega,
Lei Zhang, and Xiaoyun Chai, and Baogang Wang, and Shichong Yu, and Honggang Hu, and Yan Zou, and Qingjie Zhao, and Qingguo Meng, and Qiuye Wu
Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents.
January 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!